Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pu Han

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Targeted Oncology|October 26, 2025
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform NeurofibromasXiaojie Hu, Zhuli Wu, Jinhu Wang, et al.
Nature Communications|August 24, 2022
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escapeZhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2Xia Rao, Runchu Zhao, Zhou Tong, et al.
Nature Immunology|January 5, 2024
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virusHan Wang, Peng Yin, Tingting Zheng, et al.
Nature Immunology|January 15, 2024
Publisher Correction: Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virusHan Wang, Peng Yin, Tingting Zheng, et al.
Emerging Microbes & Infections|July 3, 2023
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBDYulei Li, Peipei Liu, Tianjiao Hao, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Journal of Virology|November 14, 2025
Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent <i>in vitro</i> and <i>in vivo</i> antiviral activitiesShuofeng Yuan, Juan Wang, Xiaohong Sang, et al.
Nature|April 26, 2023
De novo design of protein interactions with learned surface fingerprintsPablo Gainza, Sarah Wehrle, Alexandra Van Hall-Beauvais, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Targeted Oncology|October 26, 2025
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform NeurofibromasXiaojie Hu, Zhuli Wu, Jinhu Wang, et al.
Nature Communications|August 24, 2022
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escapeZhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2Xia Rao, Runchu Zhao, Zhou Tong, et al.
Nature Immunology|January 5, 2024
Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virusHan Wang, Peng Yin, Tingting Zheng, et al.
Nature Immunology|January 15, 2024
Publisher Correction: Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virusHan Wang, Peng Yin, Tingting Zheng, et al.
Emerging Microbes & Infections|July 3, 2023
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBDYulei Li, Peipei Liu, Tianjiao Hao, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Journal of Virology|November 14, 2025
Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent <i>in vitro</i> and <i>in vivo</i> antiviral activitiesShuofeng Yuan, Juan Wang, Xiaohong Sang, et al.
Nature|April 26, 2023
De novo design of protein interactions with learned surface fingerprintsPablo Gainza, Sarah Wehrle, Alexandra Van Hall-Beauvais, et al.
Pageof 10